ORTX Insider Trading Activity and SEC Form 4 Filings
ORTX insider trading summary
No open-market insider purchases or sales of Orchard Therapeutics plc (ORTX) have been reported on SEC Form 4 in the past 12 months.
Latest ORTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 1, 2022 | Bobby Gaspar | Chief Executive Officer | Buy | $11K (15,000 @ $0.74) |
| Apr 1, 2022 | Frank E Thomas | See Remarks | Buy | $7K (10,000 @ $0.75) |
| Feb 5, 2021 | FMR LLC | 10% Owner | Sell | $7.1M (1,022,755 @ $6.98) |
| Feb 5, 2021 | FMR LLC | 10% Owner | Sell | $7.1M (1,022,755 @ $6.98) |
| Sep 24, 2020 | RA Capital Healthcare Fund LP | 10% Owner | Buy | $2.2M (473,327 @ $4.61) |
| Sep 24, 2020 | Peter Kolchinsky | 10% Owner | Buy | $2.2M (473,327 @ $4.61) |
| Sep 24, 2020 | Rajeev M. Shah | 10% Owner | Buy | $2.2M (473,327 @ $4.61) |
| Sep 24, 2020 | Ra Capital Management, L.P. | 10% Owner | Buy | $2.2M (473,327 @ $4.61) |
| Aug 21, 2020 | Rajeev M. Shah | 10% Owner | Buy | $46K (10,226 @ $4.51) |
| Aug 21, 2020 | Rajeev M. Shah | 10% Owner | Buy | $252K (54,416 @ $4.64) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.